Logo image of SRAD

SPORTRADAR GROUP AG-A (SRAD) Stock Fundamental Analysis

NASDAQ:SRAD - Nasdaq - CH1134239669 - Common Stock - Currency: USD

24  -0.04 (-0.17%)

After market: 24 0 (0%)

Fundamental Rating

6

Taking everything into account, SRAD scores 6 out of 10 in our fundamental rating. SRAD was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. SRAD is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. SRAD is valued quite expensively, but it does show have an excellent growth rating. With these ratings, SRAD could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

SRAD had positive earnings in the past year.
In the past year SRAD had a positive cash flow from operations.
In the past 5 years SRAD has always been profitable.
Each year in the past 5 years SRAD had a positive operating cash flow.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

SRAD's Return On Assets of 2.32% is in line compared to the rest of the industry. SRAD outperforms 52.24% of its industry peers.
SRAD's Return On Equity of 6.05% is fine compared to the rest of the industry. SRAD outperforms 63.43% of its industry peers.
With a Return On Invested Capital value of 4.33%, SRAD perfoms like the industry average, outperforming 44.78% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for SRAD is significantly below the industry average of 13.88%.
The last Return On Invested Capital (4.33%) for SRAD is above the 3 year average (3.32%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.32%
ROE 6.05%
ROIC 4.33%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

SRAD has a Profit Margin (5.12%) which is in line with its industry peers.
SRAD's Profit Margin has been stable in the last couple of years.
SRAD has a Operating Margin of 10.79%. This is comparable to the rest of the industry: SRAD outperforms 55.22% of its industry peers.
In the last couple of years the Operating Margin of SRAD has remained more or less at the same level.
The Gross Margin of SRAD (73.07%) is better than 90.30% of its industry peers.
SRAD's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.79%
PM (TTM) 5.12%
GM 73.07%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRAD is destroying value.
SRAD has more shares outstanding than it did 1 year ago.
SRAD has more shares outstanding than it did 5 years ago.
The debt/assets ratio for SRAD has been reduced compared to a year ago.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 3.26 indicates that SRAD is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.26, SRAD is doing good in the industry, outperforming 79.10% of the companies in the same industry.
SRAD has a debt to FCF ratio of 0.33. This is a very positive value and a sign of high solvency as it would only need 0.33 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 0.33, SRAD belongs to the best of the industry, outperforming 92.54% of the companies in the same industry.
SRAD has a Debt/Equity ratio of 0.04. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.04, SRAD belongs to the best of the industry, outperforming 85.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.33
Altman-Z 3.26
ROIC/WACC0.75
WACC5.8%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

SRAD has a Current Ratio of 1.35. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
SRAD's Current ratio of 1.35 is fine compared to the rest of the industry. SRAD outperforms 69.40% of its industry peers.
SRAD has a Quick Ratio of 1.35. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of SRAD (1.35) is better than 73.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.35
Quick Ratio 1.35
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

9

3. Growth

3.1 Past

SRAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 69.23%, which is quite impressive.
SRAD shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 21.84% yearly.
Looking at the last year, SRAD shows a very strong growth in Revenue. The Revenue has grown by 23.08%.
SRAD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.81% yearly.
EPS 1Y (TTM)69.23%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%4073.68%
Revenue 1Y (TTM)23.08%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%17.05%

3.2 Future

SRAD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 66.45% yearly.
The Revenue is expected to grow by 12.68% on average over the next years. This is quite good.
EPS Next Y166.75%
EPS Next 2Y97.75%
EPS Next 3Y81.32%
EPS Next 5Y66.45%
Revenue Next Year17.94%
Revenue Next 2Y16.57%
Revenue Next 3Y15.86%
Revenue Next 5Y12.68%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

3

4. Valuation

4.1 Price/Earnings Ratio

SRAD is valuated quite expensively with a Price/Earnings ratio of 96.00.
Compared to the rest of the industry, the Price/Earnings ratio of SRAD indicates a slightly more expensive valuation: SRAD is more expensive than 61.19% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.19, SRAD is valued quite expensively.
SRAD is valuated quite expensively with a Price/Forward Earnings ratio of 49.46.
Compared to the rest of the industry, the Price/Forward Earnings ratio of SRAD indicates a slightly more expensive valuation: SRAD is more expensive than 61.19% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.13, SRAD is valued quite expensively.
Industry RankSector Rank
PE 96
Fwd PE 49.46
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as SRAD.
The rest of the industry has a similar Price/Free Cash Flow ratio as SRAD.
Industry RankSector Rank
P/FCF 40.42
EV/EBITDA 14.41
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

SRAD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SRAD may justify a higher PE ratio.
A more expensive valuation may be justified as SRAD's earnings are expected to grow with 81.32% in the coming years.
PEG (NY)0.58
PEG (5Y)4.4
EPS Next 2Y97.75%
EPS Next 3Y81.32%

0

5. Dividend

5.1 Amount

SRAD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (5/29/2025, 8:15:02 PM)

After market: 24 0 (0%)

24

-0.04 (-0.17%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)N/A N/A
Inst Owners85.37%
Inst Owner Change2.14%
Ins Owners2.22%
Ins Owner ChangeN/A
Market Cap7.17B
Analysts83.81
Price Target27.27 (13.62%)
Short Float %3.2%
Short Ratio3.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)20.63%
Min EPS beat(2)-100%
Max EPS beat(2)141.26%
EPS beat(4)2
Avg EPS beat(4)54.91%
Min EPS beat(4)-100%
Max EPS beat(4)278.4%
EPS beat(8)3
Avg EPS beat(8)13.27%
EPS beat(12)5
Avg EPS beat(12)-16.74%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.98%
Min Revenue beat(2)-0.42%
Max Revenue beat(2)2.39%
Revenue beat(4)3
Avg Revenue beat(4)2.56%
Min Revenue beat(4)-0.42%
Max Revenue beat(4)4.89%
Revenue beat(8)4
Avg Revenue beat(8)0.37%
Revenue beat(12)7
Avg Revenue beat(12)0.8%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.31%
PT rev (3m)34.54%
EPS NQ rev (1m)-23.78%
EPS NQ rev (3m)-37.5%
EPS NY rev (1m)6.46%
EPS NY rev (3m)15.39%
Revenue NQ rev (1m)-0.58%
Revenue NQ rev (3m)-0.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.14%
Valuation
Industry RankSector Rank
PE 96
Fwd PE 49.46
P/S 5.52
P/FCF 40.42
P/OCF 16.39
P/B 6.53
P/tB N/A
EV/EBITDA 14.41
EPS(TTM)0.25
EY1.04%
EPS(NY)0.49
Fwd EY2.02%
FCF(TTM)0.59
FCFY2.47%
OCF(TTM)1.46
OCFY6.1%
SpS4.35
BVpS3.68
TBVpS-3.27
PEG (NY)0.58
PEG (5Y)4.4
Profitability
Industry RankSector Rank
ROA 2.32%
ROE 6.05%
ROCE 5.9%
ROIC 4.33%
ROICexc 5.22%
ROICexgc N/A
OM 10.79%
PM (TTM) 5.12%
GM 73.07%
FCFM 13.66%
ROA(3y)1.27%
ROA(5y)1.22%
ROE(3y)3.04%
ROE(5y)3.99%
ROIC(3y)3.32%
ROIC(5y)3.53%
ROICexc(3y)4.06%
ROICexc(5y)5.55%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.52%
ROCE(5y)4.82%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y7.36%
ROICexc growth 5Y-3.96%
OM growth 3Y8.52%
OM growth 5Y-0.79%
PM growth 3Y11.19%
PM growth 5Y0.07%
GM growth 3Y-2.3%
GM growth 5Y-2.62%
F-Score7
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF 0.33
Debt/EBITDA 0.1
Cap/Depr 77.98%
Cap/Sales 20.03%
Interest Coverage 1.57
Cash Conversion 92.36%
Profit Quality 266.99%
Current Ratio 1.35
Quick Ratio 1.35
Altman-Z 3.26
F-Score7
WACC5.8%
ROIC/WACC0.75
Cap/Depr(3y)86.86%
Cap/Depr(5y)86.55%
Cap/Sales(3y)21.89%
Cap/Sales(5y)22.44%
Profit Quality(3y)195.32%
Profit Quality(5y)194.81%
High Growth Momentum
Growth
EPS 1Y (TTM)69.23%
EPS 3Y38.99%
EPS 5Y21.84%
EPS Q2Q%4073.68%
EPS Next Y166.75%
EPS Next 2Y97.75%
EPS Next 3Y81.32%
EPS Next 5Y66.45%
Revenue 1Y (TTM)23.08%
Revenue growth 3Y25.4%
Revenue growth 5Y23.81%
Sales Q2Q%17.05%
Revenue Next Year17.94%
Revenue Next 2Y16.57%
Revenue Next 3Y15.86%
Revenue Next 5Y12.68%
EBIT growth 1Y32.84%
EBIT growth 3Y36.08%
EBIT growth 5Y22.83%
EBIT Next Year117.47%
EBIT Next 3Y51.41%
EBIT Next 5Y36.19%
FCF growth 1Y877.26%
FCF growth 3Y347.38%
FCF growth 5Y21.32%
OCF growth 1Y111.14%
OCF growth 3Y38.73%
OCF growth 5Y19.31%